Login / Signup

Montelukast as a Rescue and Premedication for Rituximab Infusion Reactions.

Lindsay AmattoElaine A Yacyshyn
Published in: The Journal of rheumatology (2024)
Rituximab (RTX) is a monoclonal antibody often used in patient treatment of malignancies and several rheumatological disorders, including vasculitides. 1-3 It has become an essential component of many treatment protocols; however, is commonly associated with hypersensitivity infusion reactions. 1 .
Keyphrases
  • monoclonal antibody
  • chronic lymphocytic leukemia
  • replacement therapy
  • smoking cessation